AL 2354AAlternative Names: AL-2354A
Latest Information Update: 12 Nov 2016
At a glance
- Originator Alcon
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Dry eyes
Most Recent Events
- 10 Dec 2015 Discontinued for Dry eyes in Switzerland (Ophthalmic)
- 15 Sep 2011 Investigation in Dry eyes in Switzerland (Ophthalmic)